Aurinia Pharmaceuticals
AUPH
#4678
Rank
ยฃ1.64 B
Marketcap
ยฃ12.29
Share price
1.54%
Change (1 day)
8.61%
Change (1 year)

Operating Margin for Aurinia Pharmaceuticals (AUPH)

Operating Margin as of November 2026 (TTM): 40.33%

According to Aurinia Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is 40.33%. At the end of 2021 the company had an Operating Margin of -395.15%.

Operating Margin history for Aurinia Pharmaceuticals from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2021-395.15%92.69%
2020-205.06%-99.47%
2019-38,900.00%181.21%
2018-13,833.05%-17.93%
2017-16,855.24%25.18%
2016-13,465.32%70.06%
2015-7,917.87%32.23%
2014-5,988.13%787.2%
2013-674.95%326.79%
2012-158.15%-39.07%
2011-259.56%62.63%
2010-159.60%-28.28%
2009-222.53%-44.77%
2008-402.88%-72.19%
2007-1,448.70%123.3%
2006-648.76%-73.72%
2005-2,468.35%39.37%
2004-1,771.13%834.53%
2003-189.52%7579.53%
2002-2.47%-98.22%
2001-138.74%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Regeneron Pharmaceuticals
REGN
33.25%-17.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-59.78%-248.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-87.72%-317.51%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.